From 30th to 31st May 2023, the 4th BIONNOVA Leaders Forum China 2023 is convened at Shanghai Marriott Hotel Parkview.
The Forum provides a platform of discussion over an array of issues including cell and gene therapy, antibody drugs, nucleic acid drugs & vaccines, clinical development & tumor immunology, small molecule drugs, investment & financing, innovation & collaboration, just to name a few. Wanhuida Intellectual Property is a co-sponsor of the Forum.
On May 30th, the firm’s Partner Wang Rui speaks on “How could patent facilitate innovation of nucleic acid drugs” at the panel themed “Innovation of Nucleic Acid Drugs & Vaccines”. Ms. Wang shares with the attendees takeaways on leveraging patent application and search in fueling and protecting innovation as well as the cultivation of high-value patent in the nucleic acid pharmaceutical industry.
The firm’s Partner Hu Honghui and Patent Attorney Xie Chuanfang also attend the Forum.
Copyright 2024 版權(quán)所有：萬慧達(dá)知識(shí)產(chǎn)權(quán) ICP備13010463號(hào)-3 京公網(wǎng)安備11010802023805號(hào)